References
- Balasch, J. (2009). Treatment of infertility and early pregnancy loss in the antiphospholipid syndrome. Handbook of Systemic Autoimmune Diseases, 196–205. Elsevier Ltd.
- Bick, R. L. (2008). Antiphospholipid thrombosis syndrome. Hematology/Oncology Clinics of North America, 22(2), 107–120.
- Cervera, R., & Asherson, R. A. (2008). Diagnostic criteria in autoimmune diseases. New York, NY: Springer Science/Humana Press/Bussiness Media LLC.
- Cung, T. T. T., Le, T. A. D., & Tran, T. T. H. (2012). A study on etiology and relative factor on recurrent pregnancy loss. Journal of Practical Medicine, 4, 91–94.
- Dendrinos, S., & Makrakis, E. (2005). A study of pregnancy loss in 352 women with recurrent miscarriages. Archives of Gynecology and Obstetrics, 271, 235–239.
- Dendrinos, S., Sakkas, E., & Makrakis, E. (2009). Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome. International Journal of Gynecology & Obstetrics, 104(3), 223–225.
- Denise, C. A., & Dombeck, M. T. B. (2010). Maternal assignment of fetal personhood to a previous pregnancy loss: Relationship to anxiety in the current pregnancy. Health Care for Women International, 22(7), 649–665.
- Edmonds, D. K. (2007). Dewhurt's textbook of obstetrics and gynaecology. London, UK: Blackwell Publishing.
- Fishman, P., Falach-Vaknine, E., & Zigelman, R. (1993). Prevention of fetal loss in experimental anti-phospholipid syndrome by in vivo administration of recombinant interleukin-3. The Journal of Clinical Investigation, 91, 1834–1837.
- Golan, A. (1989). Congenital anomalies of the mullerian system. Fertility and Sterility, 51(5), 747–755.
- Greer, I. A. (2010). Antithrombotic therapy for recurrent miscarriage? The New England Journal of Medicine, 362(17), 1630–1631.
- Hachem, H. E., Crepaux, V., & May-Panloup, P. (2017). Recurrent pregnancy loss: Current perspectives. International Journal of Women's Health, 9, 331–345.
- Jaslow, C. R., Carney, J. L., & Kutteh, W. H. (2010). Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertility and Sterility, 93(4), 1234–1243.
- Khamashta, M. A., & Mackworth, Y. C. (1997). Antiphospholipid syndrome – A treatable cause of recurrent pregnancy loss. British Medical Journal, 314, 244.
- Kiwi, R. (2006). Recurrent pregnancy loss: Evaluation and discussion of the causes and their management. Clevel and Clinic Journal of Medicine, 73(10), 913–921.
- Le, T. A. D. (2010). Some comments on recurrent pregnancy loss at National hospital of obstetrics and gynecology 2008. Journal of Practical Medicine, 7, 77–81.
- Le, T. P. L., Hoang, M. P., & Do, T. D. (2011). Further research on Antiphospholipid syndrome and pregnancy. The French-Vietnamese Conference on Obstetrics and Gynecology Proceedings, 1, 256–265.
- Peters, A., Lloyd, R. P., & Coulam, C. B. (1992). Prevalence of out-of-phase endometrial biopsy specimens. American Journal of Obstetrics & Gynecology, 166, 1738–1746.
- Sotiriadis, A., Makrigiannakis, A., & Stefos, T. (2007). Fibrinolytic defects and recurrent miscarriage: A systematic review and meta-analysis. Obstetrics & Gynecology, 109, 1146–1155.